Salamanca, Spain

Rogelio Gonzalez Sarmiento


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Remarkable Journey of Inventor Rogelio Gonzalez Sarmiento

Introduction

Rogelio Gonzalez Sarmiento is an innovative inventor based in Salamanca, Spain. He has made significant contributions to the field of medical science, particularly in cancer treatment. With one patent to his name, Sarmiento's work is a testament to the intersection of research and application in the medical world.

Latest Patents

Rogelio Gonzalez Sarmiento holds a patent for an "Anti-presenilin antibody for use in the prevention and/or treatment of cancer." This groundbreaking invention involves an antibody or fragment that targets presenilin, specifically the luminal loop of presenilin. The patent describes its efficacy in treating cancer, advocating for the administration of a therapeutically effective quantity of the antibody or a pharmaceutical composition that contains it to patients suffering from cancer.

Career Highlights

Throughout his career, Sarmiento has been associated with notable organizations, including Alzheimur 2012 S.L. and Fundación Universitaria San Antonio. His work in these institutions has been integral in advancing the understanding and treatment of conditions related to presenilin.

Collaborations

Rogelio has collaborated with distinguished colleagues in his field, including Miguel Rodriguez Manotas and Javier Fernandez Mateos. These partnerships reflect the collaborative spirit essential in research and innovation.

Conclusion

Rogelio Gonzalez Sarmiento stands as a key figure in the realm of medical innovation, particularly in cancer treatment. His patented work contributes to the ongoing efforts in scientific research and paves the way for future developments in effective therapies. His journey exemplifies the vital role inventors play in transforming healthcare through innovative ideas and collaborations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…